|
|
||||||||
Review |
Department of Pathology and Laboratory Medicine, Hartford Hospital, Hartford, CT 06102.
a Author for correspondence. Fax 860-545-5206;
Molecular diagnostic assays have become routine in the evaluation of lymphoid malignancies. Both Southern transfer and polymerase chain reaction (PCR) technologies are used to assess for B- and T-cell clonality, the presence of rearrangements involving protooncogenes such as bcl-1 and bcl-2, and the monitoring of minimal residual disease. We review the fundamentals of B- and T-cell ontogeny as well as the basic principles of the Southern transfer and PCR assays and their applications to the diagnosis of lymphoid malignancies.
The following articles in journals at HighWire Press have cited this article:
![]() |
R. C. Burnett, W. Vernau, J. F. Modiano, C. S. Olver, P. F. Moore, and A. C. Avery Diagnosis of Canine Lymphoid Neoplasia Using Clonal Rearrangements of Antigen Receptor Genes Vet. Pathol., January 1, 2003; 40(1): 32 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Munro, K. Snow, J. A. Kant, and J. P. Landers Molecular Diagnostics on Microfabricated Electrophoretic Devices: From Slab Gel- to Capillary- to Microchip-based Assays for T- and B-Cell Lymphoproliferative Disorders Clin. Chem., November 1, 1999; 45(11): 1906 - 1917. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |